David Sell

Type: Person

Name: David Sell

First reported May 24 2013 - Updated May 24 2013 - 1 reports

Actavis CEO: Ireland Great for Paying Less Tax, But “Everybody Loves New Jersey too Much” to Leave

In the PhillyPharma column, David Sell rakes Actavis over the coals for its purchase of Ireland-based Warner Chilcott. U.S. pharma companies, he says, are no better than Apple ? hiding money offshore to avoid paying their fair share of U.S. taxes. Ph ... [Published FDA News - May 24 2013]

Entities: Actavis, Ireland, David Sell, Warner Chilcott plc

First reported May 23 2013 - Updated May 23 2013 - 1 reports

GlaxoSmithKline plc

Glaxo unit to work on public-private antibiotics research

Glaxo-SmithKline is participating in the U.S. government's $200 million program to fight antibiotic- resistant infections around the world.Travel DealsDavid Sell, Inquirer Staff WriterA local unit of drugmaker GlaxoSmithKline has a central role in a $200 ... [Published Philly.com - May 23 2013]

Entities: GlaxoSmithKline plc, Antibiotic, infections, David Sell

First reported May 21 2013 - Updated May 21 2013 - 2 reports

National institutes of Health

Casey promotes health-care research as job source

U.S. Sen. Bob Casey says he doesn't have an answer to the national need for balance in creating health-care financing solutions, but he knows that National Institutes of Health funding helps put and keep jobs in the Philadelphia region."I focus on NIH ... [Published Individual.com - May 21 2013]

Entities: Bob Casey, National institutes of Health, David Sell, Francis Collins

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Teva Pharmaceutical Industries Ltd

Teva treads lightly in morning-after controversy

An employee enters the Teva headquarters in North Wales, Montgomery County.Travel DealsThe recent controversy surrounding the morning-after contraceptive pill called Plan B One-Step has been argued in political, regulatory, and legal circles. But Teva ... [Published Philly.com - May 17 2013]

Entities: Teva Pharmaceutical Industries Ltd, FDA Food & Drug Administration, Kathleen Sebelius, Contraceptive

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Angelina Jolie

Jolie's revelation has business, legal angles

Myriad Genetics in Salt Lake City is at the center of a legal debate on gene patenting.Travel DealsThe revelation this week by the film star Angelina Jolie of a double mastectomy to help avoid breast cancer had business and legal angles as well.Myriad ... [Published Philly.com - May 16 2013]

Entities: Myriad Genetics Inc, Angelina Jolie, Monsanto Company, Patent

First reported May 14 2013 - Updated May 14 2013 - 1 reports

FDA Food & Drug Administration

Endo hit hard by FDA's refusal to reject generics

Endo's stock fell 5 percent Friday, then 3.6 percent more Monday, closing at $33.71.vern-based Endo Health Solutions Inc. dealt Monday with the fallout from an adverse decision Friday by the Food and Drug Administration, which rejected Endo's complicated ... [Published Philly.com - May 14 2013]

Entities: FDA Food & Drug Administration, Opana ER, opioid, anodyne

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Merck & Co Inc

Merck workers keep working after deadline

The 2,000 or so union employees and management at the Merck & Co. plant in West Point, Montgomery County, agreed to continue working and negotiating after the union contract expired Tuesday night.Weeks of negotiations and news of weak first-quarter financial ... [Published Philly.com - May 02 2013]

Entities: Merck & Co Inc, Roger Perlmutter, Deadline

First reported May 01 2013 - Updated May 01 2013 - 1 reports

Pfizer sales decline; challenges foreseen

Among the factors clouding Pfizer's financial picture are recent changes in foreign currency rates.Two problems that won't go away immediately hurt drugmaker Pfizer Inc., which reported Tuesday that its sales declined 9 percent in the first quarter of ... [Published Philly.com - May 01 2013]

Entities: Pfizer Inc, Lipitor, Ian Read

First reported Apr 09 2013 - Updated Apr 09 2013 - 1 reports

U.S. consumers pay more for drugs

"True prices are nearly impossible to ascertain," said one academic who follows the pharmaceutical industry.U.S. consumers and taxpayers usually pay more - often much more - than people in other developed nations for brand-name drugs, according to a series ... [Published Philadelphia Inquirer - Apr 09 2013]

Entities: Drugs, Gerard Anderson, United States

First reported Mar 22 2013 - Updated Mar 22 2013 - 1 reports

AstraZeneca to cut 2,300 more jobs, mostly in Europe

AstraZeneca offices in England. The firm, which also has facilitiesin Delaware, announced more job cuts.The drugmaker AstraZeneca, which announced big job cuts Monday in research and development, said Thursday morning that it was would lay off 2,300 more ... [Published Philadelphia Inquirer - Mar 22 2013]

Entities: AstraZeneca PLC, Layoffs, ModeRNA Therapeutics, David Sell, Research & Development

First reported Mar 19 2013 - Updated Mar 20 2013 - 2 reports

High court argues case that could determine generic-drug makers' liability

WASHINGTON - Supreme Court justices questioned and debated Tuesday the proper reach and power of federal law in the regulation of generic drugs and whether a Philadelphia company is liable for $21 million in damages for horrific injuries suffered by a ... [Published Philadelphia Inquirer - Mar 20 2013]

Entities: Drugs, FDA Food & Drug Administration, Jay Lefkowitz, Liability

First reported Feb 02 2013 - Updated Feb 02 2013 - 2 reports

Shire to pay $57.5 million over marketing of five drugs

David Sell, Inquirer Staff WriterPosted: Saturday, February 2, 2013, 3:01 AMShire P.L.C. said Friday that it would pay $57.5 million as part of a tentative agreement with the Justice Department to settle an investigation related to marketing practices ... [Published PharmaGossip - Feb 02 2013]

Entities: Shire plc, DERMAGRAFT, David Sell, Drugs

More Content

sort by: Date \| Relevance
Actavis CEO: Ireland Great for Paying Less Tax... [Published FDA News - May 24 2013]
Glaxo unit to work on public-private antibiotic... [Published Philly.com - May 23 2013]
Casey promotes health-care research as job source [Published Individual.com - May 21 2013]
Casey promotes health-care research as job source [Published Philly.com - May 21 2013]
Casey calls for action on IRS abuses, Syria [Published Philadelphia Daily News - May 18 2013]
Teva treads lightly in morning-after controversy [Published Philly.com - May 17 2013]
Jolie's revelation has business, legal angles [Published Philly.com - May 16 2013]
The Sells will Sellabrate Life at the Relay for... [Published The Hamburg Area Item - May 16 2013]
Endo hit hard by FDA's refusal to reject generics [Published Philly.com - May 14 2013]
The Sells will Sellabrate Life at the Relay for... [Published The Boyertown Area Times - May 11 2013]
Glaxo, Merck in plan to send vaccine to Africa [Published Individual.com - May 10 2013]
Pfizer to sell Viagra online [Published PredictWallStreet - May 06 2013]
Teva to shut Sellersville plant by 2017 [Published Philly.com - May 03 2013]
Merck workers keep working after deadline [Published Philly.com - May 02 2013]
Pfizer sales decline; challenges foreseen [Published Philly.com - May 01 2013]
FDA says no to generic versions of older OxyCon... [Published Pharmacy Choice - Apr 18 2013]
FDA says no to generic versions of older OxyContin [Published Philadelphia Inquirer - Apr 17 2013]
J&J says area plant on schedule to reopen [The ... [Published Pharmacy Choice - Apr 17 2013]
J&J says area plant on schedule to reopen [Published Philadelphia Inquirer - Apr 17 2013]
Business news in brief [Published Philadelphia Inquirer - Apr 16 2013]
Monday round-up [Published SCOTUSblog - Apr 15 2013]
U.S. consumers pay more for drugs [Published Philadelphia Inquirer - Apr 09 2013]
Merck says Montgomery County jobs are safe - fo... [Published Philadelphia Inquirer - Apr 06 2013]
Why Glaxo's chief chose to keep the drugmaker i... [Published Philadelphia Inquirer - Mar 27 2013]
AstraZeneca to cut 2,300 more jobs, mostly in E... [Published Philadelphia Inquirer - Mar 22 2013]
Wednesday round-up [Published SCOTUSblog - Mar 20 2013]
High court argues case that could determine gen... [Published Philadelphia Inquirer - Mar 20 2013]
U.S. high court to take up case of generic drug... [Published Philadelphia Inquirer - Mar 19 2013]
AstraZeneca to shift or cut 1,200 jobs in Wilmi... [Published Philadelphia Inquirer - Mar 19 2013]
Business news in brief [Published Philadelphia Inquirer - Mar 19 2013]